Opportunistic infections: latest news

Opportunistic infections resources

  • PCP

    PCP is a form of pneumonia caused by a common organism, Pneumocystis jiroveci (previously called Pneumocystis carinii), which is a type of fungus. This organism...

    From: Factsheets

    Information level Level 2
  • Preventing infections

    Because HIV can weaken the immune system, it leaves the body vulnerable to some infections it would normally be able to fight off. These are...

    From: Factsheets

    Information level Level 2
  • Septrin (cotrimoxazole)

    Septrin or Bactrim are brandnames for a combination of antibiotics called cotrimoxazole. Cotrimoxazole is the main drug used to treat and to prevent PCP (Pneumocystis...

    From: Factsheets

    Information level Level 2
  • Mouth problems

    Many HIV-related conditions can affect the mouth, causing symptoms such as ulcers, dry mouth and painful lesions. Mouth problems are caused by either fungal infections,...

    From: Factsheets

    Information level Level 2
  • A to Z of illnesses

    Information on the common symptoms experienced by people with HIV or AIDS, and details of opportunistic infections, drug side-effects and other illnesses....

    From: HIV treatments directory

    Information level Level 4

Opportunistic infections features

Opportunistic infections in your own words

Opportunistic infections news from aidsmap

More news

Opportunistic infections news selected from other sources

  • More Research called for into HIV and schistosomiasis coinfection in African children

    Researchers from the Liverpool School of Tropical Medicine have called for more research to be carried out into HIV and schistosomiasis coinfection in children in sub-Saharan Africa.

    23 April 2014 | HIV / AIDS News From Medical News Today
  • Sean Strub: Whitewashing AIDS History

    In my book, I recount how slow the federal government was in publicizing the use of Bactrim and other sulfa drugs to prevent PCP (the pneumonia that was then the leading killer of people with AIDS) in addition to its long-time and well-known use to treat PCP.

    11 March 2014 | Huffington Post
  • Researchers look for culprit behind oral health problems in HIV-positive patients

    Researchers want to help HIV-positive patients live better by understanding why their essentially dormant infection is still wreaking havoc in their mouth. Even with meticulous dental hygiene, tooth decay and gum disease, as well as infections by yeast, bacteria, and viruses such as human papillomavirus, continue to plague many patients, said Dr. Josѐ A.

    24 February 2014 | HIV / AIDS News From Medical News Today
  • We urge WHO to act on cytomegalovirus retinitis

    Treatment with a simple pill, valganciclovir, is realistic in every setting. Unfortunately, with no mention of cytomegalovirus retinitis by WHO and no WHO guidelines on cytomegalovirus treatment, there has been little attention to treatment in national programmes.

    31 January 2014 | Lancet Global Health
  • Booster Shots Needed for People with HIV?

    Previous research indicates people with HIV have a reduced immune response to most vaccines, but how does immune response hold up over time—and what are the implications for re-vaccinating with “booster shots”?

    26 January 2014 | BETA blog
  • Meningococcal Disease Risk 10-Fold Higher in People With HIV

    People living with AIDS/HIV (PLWHA) are at 10-fold increased risk for contracting invasive meningococcal disease (IMD), according to a 12-year epidemiologic study published online October 29 in the Annals of Internal Medicine.

    01 November 2013 | Medscape
  • Pfizer Receives European Approval For Label Update Regarding The Use Of Prevenar 13 In Certain High-Risk Populations

    The updated label now includes information describing the use of the vaccine in preterm infants, children and adolescents with sickle cell disease who were previously vaccinated with the 23-valent pneumococcal polysaccharide vaccine, and adults with human immunodeficiency virus (HIV) infection who were previously vaccinated with the 23-valent pneumococcal polysaccharide vaccine.

    22 October 2013 | Pfizer press release
  • Fungus targets HIV patients - study

    Local researchers have discovered a new fungus that causes a potentially deadly disease in HIV-positive South Africans. The infection was caused by a newly described, but unnamed, opportunistic fungus in the type Emmonsia, and was fatal in three patients.

    15 October 2013 | Independent Online
  • CD8 Activation Predicts Clinical Events on ART, But Only in 50+

    CD8-cell activation predicts AIDS and non-AIDS conditions in people taking suppressive antiretroviral therapy (ART), but the association remained significant only in people 50 and older.

    01 October 2013 | International AIDS Society
  • Novel vaccine approach to human cytomegalovirus found effective

    An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus.

    22 September 2013 | UC Davis press release
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.